NYSE:SQZ

SQZ Biotechnologies News Headlines

$11.79
+0.13 (+1.11 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$11.29
$12.05
50-Day Range
$11.66
$15.02
52-Week Range
$11.28
$36.49
Volume593,883 shs
Average Volume166,899 shs
Market Capitalization$328.73 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

SQZ Biotechnologies (NYSE SQZ) News Headlines Today

SourceHeadline
SQZ Biotech to Present at BofA Securities 2021 Virtual Health Care ConferenceSQZ Biotech to Present at BofA Securities 2021 Virtual Health Care Conference
finance.yahoo.com - May 5 at 11:56 AM
SQZ Biotechnologies to Present New Data on Rapid Cell Therapy Manufacturing Capabilities and Advantages in Cell Performance at ASGCT 2021SQZ Biotechnologies to Present New Data on Rapid Cell Therapy Manufacturing Capabilities and Advantages in Cell Performance at ASGCT 2021
finance.yahoo.com - April 27 at 5:13 PM
SQZ Biotechnologies (NYSE:SQZ) Given Average Recommendation of "Buy" by AnalystsSQZ Biotechnologies (NYSE:SQZ) Given Average Recommendation of "Buy" by Analysts
americanbankingnews.com - April 27 at 6:31 AM
$5.84 Million in Sales Expected for SQZ Biotechnologies (NYSE:SQZ) This Quarter$5.84 Million in Sales Expected for SQZ Biotechnologies (NYSE:SQZ) This Quarter
americanbankingnews.com - April 24 at 3:48 AM
SQZ Biotechnologies (NYSE:SQZ) Expected to Announce Earnings of -$0.73 Per ShareSQZ Biotechnologies (NYSE:SQZ) Expected to Announce Earnings of -$0.73 Per Share
americanbankingnews.com - April 22 at 6:14 AM
SQZ Biotechnologies (NYSE:SQZ) Lock-Up Period Set To End  on April 28thSQZ Biotechnologies' (NYSE:SQZ) Lock-Up Period Set To End on April 28th
americanbankingnews.com - April 21 at 1:14 AM
SQZ Biotech Presents Preclinical Data on its mRNA-based enhanced APCs and the Potential of the SQZ APC Platform in KRAS Driven TumorsSQZ Biotech Presents Preclinical Data on its mRNA-based enhanced APCs and the Potential of the SQZ APC Platform in KRAS Driven Tumors
finance.yahoo.com - April 10 at 10:39 AM
SQZ Biotech to Participate in April Investor EventsSQZ Biotech to Participate in April Investor Events
finance.yahoo.com - April 6 at 8:54 AM
Earnings Update: SQZ Biotechnologies Company (NYSE:SQZ) Just Reported And Analysts Are Trimming Their ForecastsEarnings Update: SQZ Biotechnologies Company (NYSE:SQZ) Just Reported And Analysts Are Trimming Their Forecasts
finance.yahoo.com - March 20 at 1:07 PM
SQZ Biotech to Present Preclinical Data on KRAS Tumor Targets and Next Generation SQZ eAPCs at the American Association for Cancer Research (AACR) 2021 Annual MeetingSQZ Biotech to Present Preclinical Data on KRAS Tumor Targets and Next Generation SQZ eAPCs at the American Association for Cancer Research (AACR) 2021 Annual Meeting
finance.yahoo.com - March 10 at 6:42 PM
Should You Buy SQZ Biotechnologies Company (SQZ) Ahead of Earnings?Should You Buy SQZ Biotechnologies Company (SQZ) Ahead of Earnings?
finance.yahoo.com - March 9 at 2:17 PM
SQZ Biotechnologies: Cell Therapy Manufacturing PlatformSQZ Biotechnologies: Cell Therapy Manufacturing Platform
seekingalpha.com - March 8 at 12:35 PM
SQZ Biotech to Present at H.C. Wainwright Global Life Sciences ConferenceSQZ Biotech to Present at H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 3 at 7:40 AM
SQZ Biotechnologies shares are trading lower after the company priced a 3 million share offering at $20 per share.SQZ Biotechnologies shares are trading lower after the company priced a 3 million share offering at $20 per share.
benzinga.com - February 12 at 8:22 PM
Why SQZ Biotechnologies Sank on FridayWhy SQZ Biotechnologies Sank on Friday
fool.com - February 12 at 7:31 PM
SQZ Biotechnologies Under Pressure After $60M Equity Raise At 9% DiscountSQZ Biotechnologies Under Pressure After $60M Equity Raise At 9% Discount
finance.yahoo.com - February 12 at 3:22 PM
SQZ Biotech Announces Pricing of Public Offering of Common StockSQZ Biotech Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - February 12 at 10:21 AM
SQZ Biotech Announces Proposed Public Offering of Common StockSQZ Biotech Announces Proposed Public Offering of Common Stock
finance.yahoo.com - February 9 at 8:09 PM
What Is The Ownership Structure Like For SQZ Biotechnologies Company (NYSE:SQZ)?What Is The Ownership Structure Like For SQZ Biotechnologies Company (NYSE:SQZ)?
finance.yahoo.com - February 2 at 1:45 PM
SQZ Biotechnologies Announces FDA Clearance of IND Application to Allow for Clinical Trial with SQZ Activating Antigen Carriers (SQZ AACs) in Patients with HPV+ TumorsSQZ Biotechnologies Announces FDA Clearance of IND Application to Allow for Clinical Trial with SQZ Activating Antigen Carriers (SQZ AACs) in Patients with HPV+ Tumors
finance.yahoo.com - February 1 at 9:18 AM
SQZ Biotechnologies Company (SQZ)SQZ Biotechnologies Company (SQZ)
finance.yahoo.com - January 30 at 8:28 PM
SQZ Biotechnologies Presents Preclinical Data for their SQZ Tolerizing Antigen Carrier Platform in Antigen-Specific Immune Tolerance (ASIT) Digital Summit Invited TalkSQZ Biotechnologies Presents Preclinical Data for their SQZ Tolerizing Antigen Carrier Platform in Antigen-Specific Immune Tolerance (ASIT) Digital Summit Invited Talk
finance.yahoo.com - January 27 at 8:14 AM
SQZ Biotechnologies Company Registered Shs BuySQZ Biotechnologies Company Registered Shs Buy
markets.businessinsider.com - November 26 at 3:22 AM
SQZ Biotech to Present at Evercore ISI Virtual HealthCONx ConferenceSQZ Biotech to Present at Evercore ISI Virtual HealthCONx Conference
finance.yahoo.com - November 23 at 9:01 AM
SQZ Biotechnologies CoSQZ Biotechnologies Co
reuters.com - November 13 at 8:45 AM
SQZ Biotech to Present at November Virtual Investor ConferencesSQZ Biotech to Present at November Virtual Investor Conferences
finance.yahoo.com - November 13 at 8:44 AM
This page was last updated on 5/8/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.